Evidence map›Paper›PMID 30323791›Full record

ArticleFrontiers in microbiology2018

Sarconesin:

Andrea Díaz-Roa, Manuel A Patarroyo, Felio J Bello, Pedro I Da Silva

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Pep5-Cpp, a Cyclin D2-Derived Antimicrobial.Molecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Veterinary world · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sarconesin II, a New Antimicrobial Peptide Isolated fromMolecules (Basel, Switzerland) · 2019
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 2 countries.

Andrea Díaz-RoaLaboratório Especial de Toxinologia Aplicada, Instituto Butantan, São Paulo, Brazil.
Manuel A PatarroyoMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia, Bogotá, Colombia.
Felio J BelloFaculty of Agricultural and Livestock Sciences, Program of Veterinary Medicine, Universidad de La Salle, Bogotá, Colombia.
Pedro I Da SilvaLaboratório Especial de Toxinologia Aplicada, Instituto Butantan, São Paulo, Brazil.
Instituto Butantan · BRUniversidad del Rosario · COUniversidade de São Paulo · BRUniversity of La Salle · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Larval therapy (LT) is an alternative treatment for healing chronic wounds; its action is based on debridement, the removal of bacteria, and stimulating granulation tissue. The most important mechanism when using LT for combating infection depends on larval excretions and secretions (ES). Larvae are protected against infection by a spectrum of antimicrobial peptides (AMPs); special interest in AMPs has also risen regarding understanding their role in wound healing since they degrade necrotic tissue and kill different bacteria during LT.

Indexed as

antimicrobial peptideinsect peptidelarval therapysarconesinSarconesiopsis magellanica

Identifiers

PMID30323791
PMCPMC6172317
OpenAlexW2894115744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.